Tirofiban indications and usage: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

22 July 2014

7 February 2014

  • curprev 01:1001:10, 7 February 2014ShiSheng talk contribs 823 bytes +823 Created page with "__NOTOC__ {{Tirofiban}} {{CMG}}; {{AE}} {{SS}} ==Indications and Usage== AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events (combined endpoint of ..."